nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—ABCC2—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0379	0.0417	CbGpPWpGaD
Furosemide—ABCC2—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0338	0.0371	CbGpPWpGaD
Furosemide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—age related macular degeneration	0.0249	0.0274	CbGpPWpGaD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0248	0.0273	CbGpPWpGaD
Furosemide—SLC22A8—optic choroid—age related macular degeneration	0.0238	0.263	CbGeAlD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0226	0.0249	CbGpPWpGaD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0209	0.023	CbGpPWpGaD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0189	0.0208	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0189	0.0208	CbGpPWpGaD
Furosemide—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.018	0.0198	CbGpPWpGaD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0158	0.0174	CbGpPWpGaD
Furosemide—PGD—NRF2 pathway—SQSTM1—age related macular degeneration	0.0145	0.016	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0129	0.0142	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.0119	0.0131	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0115	0.0126	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0115	0.0126	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0113	0.0124	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0113	0.0124	CbGpPWpGaD
Furosemide—CA9—Cellular response to hypoxia—VEGFA—age related macular degeneration	0.011	0.0121	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0108	0.0118	CbGpPWpGaD
Furosemide—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.0107	0.0118	CbGpPWpGaD
Furosemide—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.0104	0.0114	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0096	0.0105	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0096	0.0105	CbGpPWpGaD
Furosemide—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.00956	0.0105	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0095	0.0104	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00859	0.00945	CbGpPWpGaD
Furosemide—PGD—Disease—RDH8—age related macular degeneration	0.00835	0.00918	CbGpPWpGaD
Furosemide—PGD—Disease—NMNAT1—age related macular degeneration	0.00835	0.00918	CbGpPWpGaD
Furosemide—SLCO2A1—eye—age related macular degeneration	0.00762	0.0842	CbGeAlD
Furosemide—CA14—Metabolism—NMNAT1—age related macular degeneration	0.00743	0.00817	CbGpPWpGaD
Furosemide—PGD—Disease—RPE65—age related macular degeneration	0.0073	0.00802	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NMNAT1—age related macular degeneration	0.00725	0.00797	CbGpPWpGaD
Furosemide—CA6—Metabolism—NMNAT1—age related macular degeneration	0.00725	0.00797	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00717	0.00788	CbGpPWpGaD
Furosemide—CA12—eye—age related macular degeneration	0.00717	0.0792	CbGeAlD
Furosemide—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00714	0.00785	CbGpPWpGaD
Furosemide—PGD—Metabolism—NMNAT1—age related macular degeneration	0.00699	0.00769	CbGpPWpGaD
Furosemide—CA12—connective tissue—age related macular degeneration	0.00691	0.0763	CbGeAlD
Furosemide—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00688	0.00757	CbGpPWpGaD
Furosemide—PGD—eye—age related macular degeneration	0.00679	0.075	CbGeAlD
Furosemide—CA7—Metabolism—NMNAT1—age related macular degeneration	0.00676	0.00744	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NMNAT1—age related macular degeneration	0.00676	0.00744	CbGpPWpGaD
Furosemide—PGD—retina—age related macular degeneration	0.00673	0.0744	CbGeAlD
Furosemide—PGD—connective tissue—age related macular degeneration	0.00654	0.0723	CbGeAlD
Furosemide—CA14—Metabolism—ELOVL4—age related macular degeneration	0.0065	0.00714	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00642	0.00706	CbGpPWpGaD
Furosemide—CA6—Metabolism—ELOVL4—age related macular degeneration	0.00633	0.00696	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ELOVL4—age related macular degeneration	0.00633	0.00696	CbGpPWpGaD
Furosemide—CA12—Metabolism—NMNAT1—age related macular degeneration	0.00627	0.00689	CbGpPWpGaD
Furosemide—PGD—Metabolism—ELOVL4—age related macular degeneration	0.00611	0.00672	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ELOVL4—age related macular degeneration	0.00591	0.0065	CbGpPWpGaD
Furosemide—CA7—Metabolism—ELOVL4—age related macular degeneration	0.00591	0.0065	CbGpPWpGaD
Furosemide—PGD—Disease—ABCA4—age related macular degeneration	0.00588	0.00647	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00573	0.00629	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00573	0.00629	CbGpPWpGaD
Furosemide—CA1—eye—age related macular degeneration	0.00568	0.0628	CbGeAlD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00568	0.00624	CbGpPWpGaD
Furosemide—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.00549	0.00604	CbGpPWpGaD
Furosemide—CA12—Metabolism—ELOVL4—age related macular degeneration	0.00548	0.00602	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00542	0.00596	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00527	0.00579	CbGpPWpGaD
Furosemide—CA14—Metabolism—SLC16A8—age related macular degeneration	0.00524	0.00576	CbGpPWpGaD
Furosemide—PGD—Disease—RHO—age related macular degeneration	0.00512	0.00562	CbGpPWpGaD
Furosemide—CA6—Metabolism—SLC16A8—age related macular degeneration	0.0051	0.00561	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SLC16A8—age related macular degeneration	0.0051	0.00561	CbGpPWpGaD
Furosemide—CA9—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00506	0.00556	CbGpPWpGaD
Furosemide—CA4—Metabolism—NMNAT1—age related macular degeneration	0.005	0.00549	CbGpPWpGaD
Furosemide—PGD—Metabolism—SLC16A8—age related macular degeneration	0.00492	0.00541	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0049	0.00539	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SQSTM1—age related macular degeneration	0.00488	0.00537	CbGpPWpGaD
Furosemide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.00485	0.00533	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00483	0.00531	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00483	0.00531	CbGpPWpGaD
Furosemide—CA2—Metabolism—NMNAT1—age related macular degeneration	0.00479	0.00527	CbGpPWpGaD
Furosemide—SLC22A8—eye—age related macular degeneration	0.00479	0.053	CbGeAlD
Furosemide—CA7—Metabolism—SLC16A8—age related macular degeneration	0.00477	0.00524	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC16A8—age related macular degeneration	0.00477	0.00524	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00474	0.00521	CbGpPWpGaD
Furosemide—CA1—Metabolism—NMNAT1—age related macular degeneration	0.00459	0.00505	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC16A8—age related macular degeneration	0.00441	0.00485	CbGpPWpGaD
Furosemide—CA4—Metabolism—ELOVL4—age related macular degeneration	0.00437	0.0048	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00437	0.0048	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00437	0.0048	CbGpPWpGaD
Furosemide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00428	0.0047	CbGpPWpGaD
Furosemide—CA2—Metabolism—ELOVL4—age related macular degeneration	0.00419	0.0046	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00409	0.0045	CbGpPWpGaD
Furosemide—CA9—Metabolism—NMNAT1—age related macular degeneration	0.00404	0.00444	CbGpPWpGaD
Furosemide—CA1—Metabolism—ELOVL4—age related macular degeneration	0.00401	0.00441	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00396	0.00435	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00373	0.0041	CbGpPWpGaD
Furosemide—CA2—eye—age related macular degeneration	0.00368	0.0407	CbGeAlD
Furosemide—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00367	0.00404	CbGpPWpGaD
Furosemide—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.00365	0.00401	CbGpPWpGaD
Furosemide—CA2—retina—age related macular degeneration	0.00365	0.0403	CbGeAlD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00364	0.00401	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00364	0.00401	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00359	0.00395	CbGpPWpGaD
Furosemide—SLC22A5—retina—age related macular degeneration	0.00359	0.0397	CbGeAlD
Furosemide—CA2—connective tissue—age related macular degeneration	0.00355	0.0392	CbGeAlD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00353	0.00388	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00353	0.00388	CbGpPWpGaD
Furosemide—CA9—Metabolism—ELOVL4—age related macular degeneration	0.00353	0.00388	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC16A8—age related macular degeneration	0.00352	0.00387	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC16A8—age related macular degeneration	0.00338	0.00371	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC16A8—age related macular degeneration	0.00324	0.00356	CbGpPWpGaD
Furosemide—PGD—Disease—CST3—age related macular degeneration	0.0032	0.00352	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00302	0.00332	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00299	0.00328	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F13B—age related macular degeneration	0.00289	0.00317	CbGpPWpGaD
Furosemide—PGD—Disease—TGFBR1—age related macular degeneration	0.00287	0.00316	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC16A8—age related macular degeneration	0.00284	0.00313	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00284	0.00312	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00283	0.00311	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00271	0.00298	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00271	0.00298	CbGpPWpGaD
Furosemide—CA14—Metabolism—LIPC—age related macular degeneration	0.00268	0.00295	CbGpPWpGaD
Furosemide—CA6—Metabolism—LIPC—age related macular degeneration	0.00261	0.00287	CbGpPWpGaD
Furosemide—CA5A—Metabolism—LIPC—age related macular degeneration	0.00261	0.00287	CbGpPWpGaD
Furosemide—CA14—Metabolism—CETP—age related macular degeneration	0.00259	0.00284	CbGpPWpGaD
Furosemide—PGD—Metabolism—LIPC—age related macular degeneration	0.00252	0.00277	CbGpPWpGaD
Furosemide—CA6—Metabolism—CETP—age related macular degeneration	0.00252	0.00277	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CETP—age related macular degeneration	0.00252	0.00277	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00247	0.00272	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00246	0.0027	CbGpPWpGaD
Furosemide—CA5B—Metabolism—LIPC—age related macular degeneration	0.00244	0.00268	CbGpPWpGaD
Furosemide—CA7—Metabolism—LIPC—age related macular degeneration	0.00244	0.00268	CbGpPWpGaD
Furosemide—PGD—Metabolism—CETP—age related macular degeneration	0.00243	0.00267	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00238	0.00262	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00237	0.00261	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00235	0.00259	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CETP—age related macular degeneration	0.00235	0.00259	CbGpPWpGaD
Furosemide—CA7—Metabolism—CETP—age related macular degeneration	0.00235	0.00259	CbGpPWpGaD
Furosemide—CA12—Metabolism—LIPC—age related macular degeneration	0.00226	0.00248	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00219	0.00241	CbGpPWpGaD
Furosemide—CA12—Metabolism—CETP—age related macular degeneration	0.00218	0.0024	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00216	0.00237	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00213	0.00234	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00195	0.00215	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00189	0.00208	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00189	0.00208	CbGpPWpGaD
Furosemide—CA4—Metabolism—LIPC—age related macular degeneration	0.0018	0.00198	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.0018	0.00198	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00174	0.00192	CbGpPWpGaD
Furosemide—CA4—Metabolism—CETP—age related macular degeneration	0.00174	0.00191	CbGpPWpGaD
Furosemide—CA2—Metabolism—LIPC—age related macular degeneration	0.00173	0.0019	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—VEGFA—age related macular degeneration	0.00167	0.00183	CbGpPWpGaD
Furosemide—CA2—Metabolism—CETP—age related macular degeneration	0.00167	0.00183	CbGpPWpGaD
Furosemide—CA1—Metabolism—LIPC—age related macular degeneration	0.00166	0.00182	CbGpPWpGaD
Furosemide—CA1—Metabolism—CETP—age related macular degeneration	0.0016	0.00176	CbGpPWpGaD
Furosemide—CA14—Metabolism—CD36—age related macular degeneration	0.00155	0.00171	CbGpPWpGaD
Furosemide—PGD—Disease—APOE—age related macular degeneration	0.00154	0.00169	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CD36—age related macular degeneration	0.00152	0.00167	CbGpPWpGaD
Furosemide—CA6—Metabolism—CD36—age related macular degeneration	0.00152	0.00167	CbGpPWpGaD
Furosemide—PGD—Metabolism—CD36—age related macular degeneration	0.00146	0.00161	CbGpPWpGaD
Furosemide—CA9—Metabolism—LIPC—age related macular degeneration	0.00146	0.0016	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CD36—age related macular degeneration	0.00141	0.00156	CbGpPWpGaD
Furosemide—CA7—Metabolism—CD36—age related macular degeneration	0.00141	0.00156	CbGpPWpGaD
Furosemide—CA9—Metabolism—CETP—age related macular degeneration	0.00141	0.00154	CbGpPWpGaD
Furosemide—CA14—Metabolism—APOE—age related macular degeneration	0.00137	0.00151	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.00135	0.00149	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—age related macular degeneration	0.00134	0.00147	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—age related macular degeneration	0.00134	0.00147	CbGpPWpGaD
Furosemide—CA12—Metabolism—CD36—age related macular degeneration	0.00131	0.00144	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—age related macular degeneration	0.00129	0.00142	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00129	0.00142	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00126	0.00139	CbGpPWpGaD
Furosemide—ALB—Metabolism—NMNAT1—age related macular degeneration	0.00126	0.00138	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—age related macular degeneration	0.00125	0.00137	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—age related macular degeneration	0.00125	0.00137	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—age related macular degeneration	0.00116	0.00127	CbGpPWpGaD
Furosemide—ALB—Metabolism—ELOVL4—age related macular degeneration	0.0011	0.00121	CbGpPWpGaD
Furosemide—CA4—Metabolism—CD36—age related macular degeneration	0.00105	0.00115	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00102	0.00112	CbGpPWpGaD
Furosemide—CA2—Metabolism—CD36—age related macular degeneration	0.001	0.0011	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000984	0.00108	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD36—age related macular degeneration	0.000961	0.00106	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000936	0.00103	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—age related macular degeneration	0.000922	0.00101	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000887	0.000975	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—age related macular degeneration	0.000884	0.000972	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—age related macular degeneration	0.000847	0.000932	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—age related macular degeneration	0.000844	0.000928	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—age related macular degeneration	0.000745	0.000819	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—age related macular degeneration	0.00065	0.000714	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.0006	0.00066	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000591	0.00065	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000522	0.000574	CbGpPWpGaD
Furosemide—ALB—Metabolism—LIPC—age related macular degeneration	0.000454	0.000499	CbGpPWpGaD
Furosemide—ALB—Metabolism—CETP—age related macular degeneration	0.000438	0.000482	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000309	0.00034	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—age related macular degeneration	0.000263	0.00029	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—age related macular degeneration	0.000232	0.000255	CbGpPWpGaD
